THE WHAT? Coty has reported a strong Q2 across metrics, with increased advertising and consumer promotions leading to 30 percent of sales in the quarter.
THE DETAILS Speaking on an investor call, Chief Financial Officer Laurent Mercier stated that marketing investment was increased to “capitalise on the strong momentum” of key brands including new launches Gucci Flora Gorgeous Gardenia and Burberry Hero fragrances.
Coty’s sales increased 12 percent as reported, with the Consumer Beauty business gaining sales growth momentum and market share.
The Prestige segment generated solid 12 percent reported and like-for-like growth in Q2, with prestige fragrance sales continuing to grow at a double-digit pace in Q2.
Consumer Beauty revenues increased 11 percent as reported and 12 percent like-for-like in Q2. CoverGirl, Rimmel, Sally Hansen and Max Factor all saw market gains.
THE WHY? Media reinvestment was heralded as helping to fuel the growth.
CEO Sue Y Nabi said, “The second quarter, and even more so the first half, further illustrates the virtuous cycle we have created. Strong topline growth combined with gross margin expansion and strong cost execution are generating both profit growth and re-investment in the business in the most promising opportunities.”
Full year guidance 2022 is predicted to be at the upper end of the guidance range.
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
